MARKETSOXiGENE (OXGN) Stock Gains on Positive FDA Feedback for Cancer Treatment TrialsBy Tony OwusuJun 1, 2015 3:25 PM EDT
STOCKSOxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging DataBy Adam FeuersteinNov 12, 2014 5:12 AM EST
STOCKSSuper Important Biotech and Drug Stock Events for NovemberBy Adam FeuersteinNov 3, 2014 8:24 AM EST
STOCKSBiotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, SareptaBy Adam FeuersteinOct 24, 2014 8:28 AM EDT
STOCKSBiotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'By Adam FeuersteinMar 21, 2014 7:00 AM EDT
MARKETSOxiGene (OXGN) Highlighted As Today's Perilous Reversal StockBy Scott OlsonMar 18, 2014 11:02 AM EDT
STOCKSOxigene Surprises With Positive Ovarian Cancer Study SuccessBy Adam FeuersteinMar 12, 2014 6:00 AM EDT
